Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 96,586 | 95,374 | 61,558 | 90,161 | 82,692 |
| Cost of Goods | 24,330 | 18,665 | 16,547 | 17,855 | 16,682 |
| Gross Profit | 72,256 | 76,709 | 45,011 | 72,306 | 66,010 |
| Operating Expenses | 36,065 | 42,658 | 21,720 | 41,267 | 41,924 |
| Operating Income | 36,521 | 34,716 | 23,838 | 31,894 | 24,768 |
| Interest Expense | 14,594 | 16,899 | 3,899 | 13,959 | 12,285 |
| Other Income | -429 | 35 | -114 | -449 | 112 |
| Pre-tax Income | 21,498 | 17,852 | 19,825 | 17,486 | 12,595 |
| Income Tax | 847 | 714 | -7,243 | -101 | -43 |
| Net Income Continuous | 20,651 | 17,138 | 27,068 | 17,587 | 12,638 |
| Net Income Discontinuous | -354 | N/A | N/A | N/A | N/A |
| Net Income | $20,297 | $17,138 | $36,563 | $17,587 | $12,638 |
| EPS Basic Total Ops | 0.98 | 0.84 | 1.88 | 0.92 | 0.66 |
| EPS Basic Continuous Ops | 1.00 | 0.84 | 1.40 | 0.92 | 0.66 |
| EPS Basic Discontinuous Ops | -0.02 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.97 | 0.83 | 1.86 | 0.90 | 0.65 |
| EPS Diluted Continuous Ops | 0.99 | 0.83 | 1.37 | 0.90 | 0.65 |
| EPS Diluted Discontinuous Ops | -0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $60,398 | $65,084 | $41,474 | $61,107 | $53,105 |